MedTrace Logo

Clinical Safety and Performance of GATT-Patch in Open Liver Surgery

NCT04819945 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 56

Last updated 2024-09-19

Study results available
· View outcomes & findings →

Summary

The purpose of this study is to determine the clinical safety and performance of GATT-Patch for management of haemorrhage during elective open liver surgery.

Conditions

  • Hemorrhage, Surgical

Interventions

DEVICE

GATT-Patch

Use of GATT-Patch for minimal, mild or moderate bleeding sites in open liver surgery

Sponsors & Collaborators

  • Avania

    collaborator INDUSTRY

  • GATT Technologies BV

    lead INDUSTRY

Principal Investigators

  • Stuart Head, MD PhD · GATT Technologies BV

  • Hans de Wilt, Prof. dr. · Radboud University Medical Center

  • Harry van Goor, Prof. dr. · Radboud University Medical Center

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-04-16
Primary Completion
2022-01-18
Completion
2022-02-24

Countries

  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04819945 on ClinicalTrials.gov